Efficacy and safety of primary letermovir prophylaxis for cytomegalovirus infection in paediatric patients undergoing allogeneic transplantation: a single-centre, retrospective, real-world analysis
LET is effective and safe in preventing csCMVi among Chinese children undergoing allo-HSCT. Compared to UCB recipients, children undergoing HID transplantation for the Beijing protocol develop less scCMVi up to 180 days post-HSCT.
Authors
- Aoli Zhang (ORCID: https://orcid.org/0000-0001-8381-0065)
- Xiaofan Zhu (ORCID: https://orcid.org/0000-0002-2572-6495)
- Chaoqian Jiang (ORCID: https://orcid.org/0000-0001-5387-8042)
- Lipeng Liu (ORCID: https://orcid.org/0009-0007-1139-8076)
- Yue Shang
- Yang Wan (ORCID: https://orcid.org/0000-0002-5914-3327)
- Xia Chen (ORCID: https://orcid.org/0000-0002-1077-3133)
- Fang Liu (ORCID: https://orcid.org/0000-0003-1707-5183)
- Xiaojuan Chen (ORCID: https://orcid.org/0000-0001-7330-0993)
- Yao Zou (ORCID: https://orcid.org/0000-0003-1418-7331)
- Yuanyuan Ren (ORCID: https://orcid.org/0000-0002-0681-0448)
- Ye Guo (ORCID: https://orcid.org/0009-0006-2409-041X)
- Wenyu Yang (ORCID: https://orcid.org/0009-0009-1946-0940)
- Xiaoyan Zhang (ORCID: https://orcid.org/0000-0001-6892-1082)
- Xin Wang (ORCID: https://orcid.org/0000-0002-6229-1945)
Institutions
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Clinical Hematology International
- Published
- 2025-03-14
- DOI
- https://doi.org/10.46989/001c.131683
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00